BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18684013)

  • 1. Bacterial inclusion bodies contain amyloid-like structure.
    Wang L; Maji SK; Sawaya MR; Eisenberg D; Riek R
    PLoS Biol; 2008 Aug; 6(8):e195. PubMed ID: 18684013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards revealing the structure of bacterial inclusion bodies.
    Wang L
    Prion; 2009; 3(3):139-45. PubMed ID: 19806034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of functional polypeptides in bacterial inclusion bodies.
    García-Fruitós E; Arís A; Villaverde A
    Appl Environ Microbiol; 2007 Jan; 73(1):289-94. PubMed ID: 17085715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-like properties of bacterial inclusion bodies.
    Carrió M; González-Montalbán N; Vera A; Villaverde A; Ventura S
    J Mol Biol; 2005 Apr; 347(5):1025-37. PubMed ID: 15784261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Conversion of an Enzyme from Native-like to Amyloid-like Aggregates within Inclusion Bodies.
    Elia F; Cantini F; Chiti F; Dobson CM; Bemporad F
    Biophys J; 2017 Jun; 112(12):2540-2551. PubMed ID: 28636911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloids in bacterial inclusion bodies.
    de Groot NS; Sabate R; Ventura S
    Trends Biochem Sci; 2009 Aug; 34(8):408-16. PubMed ID: 19647433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct β-sheet structure in protein aggregates determined by ATR-FTIR spectroscopy.
    Shivu B; Seshadri S; Li J; Oberg KA; Uversky VN; Fink AL
    Biochemistry; 2013 Aug; 52(31):5176-83. PubMed ID: 23837615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of amyloid fibrils.
    Maji SK; Wang L; Greenwald J; Riek R
    FEBS Lett; 2009 Aug; 583(16):2610-7. PubMed ID: 19596006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in Escherichia coli.
    Upadhyay AK; Murmu A; Singh A; Panda AK
    PLoS One; 2012; 7(3):e33951. PubMed ID: 22479486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prion-like RNA-processing protein HNRPDL forms inherently toxic amyloid-like inclusion bodies in bacteria.
    Navarro S; Marinelli P; Diaz-Caballero M; Ventura S
    Microb Cell Fact; 2015 Jul; 14():102. PubMed ID: 26160665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion bodies: specificity in their aggregation process and amyloid-like structure.
    Morell M; Bravo R; Espargaró A; Sisquella X; Avilés FX; Fernàndez-Busquets X; Ventura S
    Biochim Biophys Acta; 2008 Oct; 1783(10):1815-25. PubMed ID: 18619498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods.
    Caballero AB; Espargaró A; Pont C; Busquets MA; Estelrich J; Muñoz-Torrero D; Gamez P; Sabate R
    Curr Protein Pept Sci; 2019; 20(6):563-576. PubMed ID: 30924417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method of predicting the in vitro fibril formation propensity of Aβ40 mutants based on their inclusion body levels in E. coli.
    Sanagavarapu K; Nüske E; Nasir I; Meisl G; Immink JN; Sormanni P; Vendruscolo M; Knowles TPJ; Malmendal A; Cabaleiro-Lago C; Linse S
    Sci Rep; 2019 Mar; 9(1):3680. PubMed ID: 30842594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilization and refolding of bacterial inclusion body proteins.
    Singh SM; Panda AK
    J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-linked cellular toxicity triggered by bacterial inclusion bodies.
    González-Montalbán N; Villaverde A; Aris A
    Biochem Biophys Res Commun; 2007 Apr; 355(3):637-42. PubMed ID: 17307135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and Refolding to Amyloid Fibrils of (His)6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli.
    Li Q; Richard CA; Moudjou M; Vidic J
    J Vis Exp; 2015 Dec; (106):e53432. PubMed ID: 26709825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein aggregation and amyloid fibril formation prediction software from primary sequence: towards controlling the formation of bacterial inclusion bodies.
    Hamodrakas SJ
    FEBS J; 2011 Jul; 278(14):2428-35. PubMed ID: 21569208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
    Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
    J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.